Affimed Reports Third Quarter 2019 Financial Results and Recent Operational Progress

NEXT STORY
Predictive Oncology CEO Discusses Corporate Milestones, Unique Approach to Cancer Research in Exclusive Broadcast
PREV STORY
Helius Medical Technologies, Inc. Announces Addition of P3 Health As New Authorized PoNS Treatment™ Clinic in Toronto, Canada
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Affimed to Report Second Quarter 2021 Financial Results & Corporate Update on September 8, 2021

author_avatar
NASDAQ Market News

Apellis to Showcase Leadership in Retina at Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

author_avatar
NASDAQ Market News

Mersana Therapeutics Announces Appointment of Brian C. DeSchuytner as Senior Vice President of Finance and Product Strategy

author_avatar
NASDAQ Market News